Abstract
Purpose of Review
The purpose of this review is to discuss recent studies that have described approaches or interventions to improve hypertension medication adherence and to suggest how providers can integrate evidenced-based approaches into routine clinical care to improve medication adherence and blood pressure control.
Recent Findings
Factors that can impact medication include patient-related factors, social- and economic-related factors, health system/health care team-related factors, and therapy-related factors. Overall, a multifaceted approach is needed to improve medication adherence. Important components include (1) patient education on hypertension, its treatment modalities and its long-term complications; and (2) patient engagement building on the foundation of education. The various interventions tested have engaged patients through interactive educational sessions, health coaching, motivational interviewing, stage of change behavioral counseling, and pharmacist hypertension management.
Summary
Strategies utilizing patient education and engagement are needed to improve medication adherence and blood pressure control.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507–20.
Egan BM, Li J, Hutchison FN, Ferdinand KC. Hypertension in the United States, 1999 to 2012: progress toward healthy people 2020 goals. Circulation. 2014;130:1692–9.
Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS data brief, no 133. Hyattsville, MD: National Center for Health Statistics. 2013.
Whelton PK, Carey RM, Aronow WS, Casey DE Jr, Collins KJ, Dennison Himmelfarb C, DePalma SM, Gidding S, Jamerson KA, Jones DW, MacLaughlin EJ, Muntner P, Ovbiagele B, Smith SC Jr, Spencer CC, Stafford RS, Taler SJ, Thomas RJ, Williams KA Sr , Williamson JD, Wright JT Jr. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2017.
Collins R, MacMahon S. Blood pressure, antihypertensive drug treatment and the risks of stroke and coronary heart disease. Br Med Bull. 1994;50:272–98.
Collins R, Peto R, MacMahon S, Godwin J, Qizilbash N, Collins R, et al. Blood pressure, stroke and coronary heart diseases. Part II: effects of short-term reduction in blood pressure—an overview of the un-confounded randomized drug trials in an epidemiological context. Lancet. 1990;335:827–38.
Holman R, et al. Efficacy of atenolol and captopril in reducing the risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. Br Med J. 1998;317:713–20.
Forette F, Seux ML, Staessen JA, Thijs L, Babarskiene MR, Babeanu S, et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med. 2002;162:2046–52.
Costa FV. Compliance with antihypertensive treatment. Clin Exp Hypertens. 1996;18:463–72.
World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. p. 1–211.
Sackett DL, Haynes RB, Gibson ES, Hackett BC, Taylor DW, Roberts RS, et al. Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1:1205–7.
Lucher TF, et al. Compliance in hypertension: facts and concepts. Hypertension. 1985;3:S3–9.
•• Friedberg JP, Rodriguez MA, Watsula ME, Lin I, Wylie-Rosett J, Allegrante JP, et al. Effectiveness of a tailored behavioral intervention to improve hypertension control: primary outcomes of a randomized controlled trial. Hypertension. 2015;65(2):440–6. This study emphasizes a unique approach in providing patient-centered care through tailored phone counseling by non-physicians targeting a patient’s behaviors and self-confidence in diet, exercise, and medication adherence.
Warren-Findlow J, Seymour RB, Brunner Huber LR. The association between self-efficacy and hypertension self-care activities among African American adults. J Community Health. 2012;37(1):15–24.
Criswell TJ, Weber CA, Xu Y, Carter BL. Effect of self-efficacy and social support on adherence to antihypertensive drugs. Pharmacotherapy. 2010;30(5):432–41.
Zullig LL, Peterson ED, Bosworth HB. Ingredients of successful interventions to improve medication adherence. JAMA. 2013;310(24):2611–2.
Myers MG. Compliance in hypertension: why don’t patients take their pills? Can Med Assoc J. 1999;160:64–5.
Bloom BS. Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther. 1998;20:671–81.
Bernheim SM, Ross JS, Krumholz HM, Bradley EH. Influence of patients’ socioeconomic status on clinical management decisions: a qualitative study. Ann Fam Med. 2008;6(1):53–9.
Ross JS, Bradley EH, Busch SH. Use of health care services by lower-income and higher-income uninsured adults. JAMA. 2006;295(17):2027–36.
Schootman M, Jeffe DB, Baker EA, Walker MS. Effect of area poverty rate on cancer screening across US communities. J Epidemiol Community Health. 2006;60(3):202–7.
Brown AF, Gross AG, Gutierrez PR, Jiang L, Shapiro MF, Mangione CM. Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care. J Am Geriatr Soc. 2003;51(5):665–70.
Yelin E, Trupin L, Yazdany J. A prospective study of the impact of current poverty, history of poverty, and exiting poverty on accumulation of disease damage in systemic lupus erythematosus. Arthritis Rheum. 2017;69:1612–22.
Alter DA, Naylor CD, Austin P, Tu JV. Effects of socioeconomic status on access to invasive cardiac procedures and on mortality after acute myocardial infarction. N Engl J Med. 1999;341(18):1359–67.
Schold JD, et al. Barriers to evaluation and wait listing for kidney transplantation. CJASN. 2011;7(6):1760–7.
Materson BJ, Reda DJ, Cushman WC, Massie BM, Freis ED, Kochar MS, et al. Single drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affair Cooperative Study group on Antihypertensive Agents. N Engl J Med. 1993;328:914–92.
Leenen FH, Wilson TW, Bolli P, Larochelle P, Myers M, Handa SP, et al. Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol. 1997;13:914–20.
Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881–4.
McInnes GT. Integrated approaches to management of hypertension: promoting treatment acceptance. Am Heart J. 1999;138:S252–5.
Kruger SH, Gerber JJ. Health beliefs and compliance of black South African outpatients with antihypertensive medication. J Soc Adm Pharm. 1998;15(3):201–9.
Saounatsou M, Patsi O, Fasoi G, Stylianou M, Kavga A, Economou O, et al. The influence of the hypertensive patient’s education in compliance with their medication. Public Health Nurs. 2001;18(6):436–42.
Lu C-H, Tang ST, Lei YX, Zhang MQ, Lin WQ, Ding SH, et al. Community-based interventions in hypertensive patients: a comparison of three health education strategies. BMC Public Health. 2015;15:33.
Johnson AL, Taylor DW, Sackett DL, Dunnett CW, Shimizu AG. Self-recording of blood pressure in the management of hypertension. Can Med Assoc J. 1978;119:1034–9.
West DS, DiLillo V, Bursac Z, Gore SA, Greene PG. Motivational interviewing improves weight loss in women with type 2 diabetes. Diabetes Care. 2007;30:1081–7.
Dilorio C, et al. Using motivational interviewing to promote adherence to antiretroviral medications. J Assoc Nurses AIDS Care. 2003;14:52–62.
• Ogedegbe G, Chaplin W, Schoenthaler A, Statman D, Berger D, Richardson T, et al. A practice-based trial of motivational interviewing and adherence in hypertensive African Americans. Am J Hypertens. 2008;21(10):1137–43. This study highlights how motivational interviewing counseling as well as pill monitors may help to motivate patients to adhere to medications and health behaviors.
Carter BL, Ardery G, Dawson JD, James PA, Bergus GR, Doucette WR, et al. Physician and pharmacist collaboration to improve blood pressure control. Arch Intern Med. 2009;169:1996–2002.
Carter BL, Coffey CS, Ardery G, Uribe L, Ecklund D, James P, et al. A cluster-randomized trial of a physician\pharmacist collaborative model to improve blood pressure control. Circ Cardiovasc Qual Outcomes. 2015;8(3):235–43.
Morisky DE, Levine DM, Green LW, Shapiro S, Russell RP, Smith CR. Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health. 1983;73:153–62.
• Chen E, et al. The impact of health coaching on medication adherence in patients with poorly controlled diabetes, hypertension, and/or hyperlipidemia: a randomized controlled trial. J Am Board Fam Med. 2015;28(1):38–45. This study demonstrated that health coaching can help patients gain medical knowledge, skills, and confidence to become active and informed participants in the management of their chronic conditions.
Meinema JG, van Dijk N, Beune EJAJ, Jaarsma DADC, van Weert HCPM, Haafkens JA. Determinants of adherence to treatment in hypertensive patients of African descent and the role of culturally appropriate education. Zeeb H, ed. PLoS One 2015;10(8):e0133560.
Broadbent E, Petrie KJ, Main J, Weinman J. The brief illness perception questionnaire. J Psychosom Res. 2006;60(6):631–7.
Schoenthaler A, Ogedegbe G, Allegrante JP. Self-efficacy mediates the relationship between depressive symptoms and medication adherence among hypertensive African Americans. Health Educ Behav. 2009;36(1):127–37.
Brus H, van de Laar M, Taal E, Rasker J, Wiegman O. Determinants of compliance with medication in patients with rheumatoid arthritis: the importance of self-efficacy expectations. Patient Educ Couns. 1999;36(1):57–64.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare no conflicts of interest relevant to this manuscript.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Additional information
This article is part of the Topical Collection on Implementation to Increase Blood Pressure Control: What Works?
Rights and permissions
About this article
Cite this article
Roldan, P.C., Ho, G.Y. & Ho, P.M. Updates to Adherence to Hypertension Medications. Curr Hypertens Rep 20, 34 (2018). https://doi.org/10.1007/s11906-018-0830-x
Published:
DOI: https://doi.org/10.1007/s11906-018-0830-x